Jiuzhou Pharmaceutical (603456.SH) subsidiary tandospirone citrate tablets obtained drug registration certificate

Zhitong Finance App News, Jiuzhou Pharmaceutical (603456.SH) issued an announcement. Recently, Jiuzhou Biopharmaceutical (Taizhou) Co., Ltd., a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for tandospirone citrate tablets approved and issued by the State Drug Administration. Tandospirone citrate tablets are an anti-anxiety drug, mainly used for anxiety states caused by various neuroses, such as generalized anxiety disorder; anxiety associated with somatic diseases such as primary hypertension and peptic ulcers.